Medical Terminology

armodafinil

« Back to Glossary Index

Armodafinil (Nuvigil, Acronite, Armoda, Armod, Artivil, Neoresotyl, R-Modawake, Waklert, Modavital) is a non-stimulant wake-promoting medication. While it is not completely known how this medication works, it appears to influence the brain chemistry that increases wakefulness, particularly the neurotransmitter dopamine. Armodafinil is a single-isomer of modafinil (Provigil), another wake-promoting medication, and was approved by the U.S. FDA in 2007 to improve wakefulness in people with excessive sleepiness caused by narcolepsy, obstructive sleep apnea and shift work sleep disorder. Armodafinil can interact with hormonal birth control to make it less effective (learn more HERE), and can result in a life-threatening rash. In addition, armodafinil can sometimes result in headaches, which, if severe enough, can cause a user to reduce the dosage, thereby limiting the effectiveness of the medication. Read more about armodafinil at MedlinePlus.gov HERE and on HF’s Treatment web page HERE.

Synonyms:
Nuvigil, Acronite, Armoda, Armod, Artivil, Neoresotyl, R-Modawake, Waklert, Modavital
Related Articles:
Disclaimer

The contents of this website, including text, graphics and other material, are for informational purposes only. This website is not intended to be a substitute for professional legal or medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Always consult your own attorney or other legal advisor with any legal questions you may have. The Hypersomnia Foundation does not recommend or endorse any specific tests, physicians, lawyers, legal advisors, products, procedures, opinions or other information referenced on this website. Reliance on any information on this website is solely at your own risk.

The Hypersomnia Foundation makes no representations or warranties about the satisfaction of any government regulations requiring disclosure of information on prescription drug products. In no event shall The Hypersomnia Foundation be liable for any damages (including without limitation incidental and consequential damages) or costs (including without limitation attorney’s fees) based on any claim arising from the use of this website and/or its content.